Clinical Trial Update: Nivolumab and RT in Treating Patients With Localized/Locally Advanced Urothelial Bladder Cancer Ineligible for Chemo [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating nivolumab with radiotherapy in localized/locally advanced urothelial bladder cancer patients ineligible for chemotherapy; completed wit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Urothelial Carcinoma

Drugs mentioned

• nivolumab (nivolumab)

Snippet

Sponsor: Barbara Ann Karmanos Cancer Institute | Conditions: Stage II Bladder Urothelial Carcinoma AJCC v6 and v7, Stage III Bladder Urothelial Carcinoma AJCC v6 and v7 | Phase 2 | Status: COMPLETED | Results posted: 2023-08-04